WonderTx YC Application

Summer 2026Active

San Francisco

WonderTx went through Y Combinator in the Summer 2026 batch as a Healthcare company. Below: what the company does, who founded it, and its application to YC, reconstructed question by question in the real YC form.

YC batch: Summer 2026
Industry: HealthcareTherapeutics
Location: San Francisco
Team size: 3
Status: Active
Launched: 2026

Founders

Abraham HeifetsFounder/CEO

What WonderTx does

We’re an AI-native biotech, working on replacing needles with pills. Many drugs, like insulin or Ozempic, are wonderful except you have to inject them. We discover new molecules that you can take as a pill instead. Because the pills operate on biology which has been shown to be effective in people, rather than merely in animal models of disease, we avoid what has historically been the single biggest risk in drug discovery. This should dramatically increase our probability of success. There’s $200B of treatable diseases and validated human biology without a pill because discovery programs lack a tractable chemical starting point. This is a zero-shot inference problem, because these targets have no training data, so LLMs and other historical interpolative AI approaches are insufficient. Instead, we are building our own extrapolative frontier models that reason beyond their training data. Most critically, we have repeatedly validated our platform on both our own and partner programs. On 4 biologically- and structurally-diverse targets where we had zero training data, we successfully picked binders that were validated experimentally, with confirmation ranging from primary screen hits to crystallographic structures.

WonderTx's YC application, reconstructed

Y Combinator application

WonderTx, Summer 2026 batch. The real form questions, answered from public data.

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

WonderTx

Describe what your company does in 50 characters or less.

AI discovers pills to replace injectable drugs

What is your company going to make? Please describe your product and what it does or will do.

We are building an AI-native biotech platform for oral drug discovery. Our tech designs new molecules that let you take, for example, insulin or Ozempic as a pill instead of a shot. Our models are trained to reason on targets that have worked in real humans, not just in animal models, removing the main risk in drug discovery. Drug discovery teams use our molecules to pursue first-in-class oral drugs for validated biology where there was no tractable starting point before.

Where do you live now, and where would the company be based after YC?

We are based in San Francisco, CA, USA, and work remotely. After YC, we will remain based in San Francisco and remote.

Explain your decision regarding location.

San Francisco has a deep biotech and AI ecosystem, which helps on both the research and fundraising side. Our work is computational and experimental, so we work distributed, but physically close to the Bay Area network.

21 more answers in the full application

Founders, Progress, Idea, Equity, Curious, Batch Preference are in the full version. Create a free account to open it in YC Insights, next to every other YC batch.

See full application

Frequently Asked Questions

Is this the real WonderTx YC application?

No. Y Combinator keeps submitted applications private. This is a reconstruction: the real YC form questions, answered from WonderTx's public data (launch notes, founder backgrounds, product description). It shows how a company like WonderTx would present itself to YC, not the text they submitted.